Roundtable participants include Drs Tomasz M Beer, Robert Dreicer, Mario A Eisenberger, William K Oh, Daniel P Petrylak, A Oliver Sartor, Susan F Slovin and Matthew R Smith. (Audio Content)

Clinical investigators provide concise comments on the projected utility of cabozantinib and MDV3100 in the treatment algorithm for prostate cancer, therapeutic options subsequent to the administration of sipuleucel-T, quality of life with docetaxel and cabazitaxel and use of growth factors when administering cabazitaxel. Featuring perspectives from Drs Robert Dreicer, Daniel J George, Gary R Hudes, Philip Kantoff, Christopher J Logothetis, Daniel P Petrylak, A Oliver Sartor and Nicholas J Vogelzang.

Featuring Dr Matthew R Smith’s perspective on a day spent visiting patients with prostate cancer in the clinic of community oncologist Dr Stacey B Leibowitz. (Audio Content)

Featuring interviews with Drs E David Crawford, Christopher J Logothetis, Robert Dreicer and Allan Lipton. (Audio Content)

This series of activities is comprised of abbreviated slide sets along with edited commentary from clinical investigators summarizing the significance of results presented at the ASCO 2011 Annual Meeting. Tumor types that are highlighted include melanoma, GIST and breast, lung, ovarian, colorectal and genitourinary cancers.

Featuring a roundtable discussion with Drs Stephen J Freedland, Daniel J George, Philip Kantoff, William K Oh and A Oliver Sartor. (Audio Content)

Highlights from a roundtable featuring a community oncologist panel and Drs Anthony V D’Amico, Laurence Klotz, Judd W Moul, William K Oh and Daniel P Petrylak. (Audio Content)